Photo by: AP Photo/The MetroWest Daily News, Allan Jung In this April 8, 2013 photo, Dick Hoyt, left, talks with his son Rick as he wheels him next to a statue dedicated in their honor in front of the Center School in Hopkinton, Mass. Dick has pushed his son Rick, who is a quadriplegic and has cerebral palsy, along the 26.2-mile Boston Marathon route for 30 years. They plan to compete again in Monday's race. Image HOLLAND, Mass. (AP) The year was 1992, and Dick Hoyt and his son, Rick, wanted to run and bike across the country to raise funds for a charity for cerebral palsy a condition 30-year-old Rick developed at birth. But the charity didn't want anything to do with a trek across the United States. "And, uh, so this insurance company that was going to finance us backed out with four weeks to go before so we had to refinance our house here so we are able to pick up the expenses," Dick Hoyt recalled recently, sitting next to his quadriplegic son at their home in the hills of western Massachusetts. Twenty-one years later, after running, biking and swimming together in some of the world's highest-profile … Continue reading →

The year was 1992, and Dick Hoyt and his son, Rick, wanted to run and bike across the country to raise funds for a charity for cerebral palsy a condition 30-year-old Rick developed at birth. But cerebral palsy didnt want anything to do with a trek across the United States. And, uh, so this insurance company that was going to finance us backed out with four weeks to go before so we had to refinance our house here so we are able to pick up the expenses, Dick Hoyt recalled recently, sitting next to his quadriplegic son at their home in the hills of western Massachusetts. Twenty-one years later, after running, biking and swimming together in some of the worlds highest-profile competitions, 73-year-old father and 51-year-old son are among the most recognized faces at the granddaddy of them all the Boston Marathon. One of the races sponsors recently unveiled a life-size statue in their honor in the town where the race starts. Another backer, Timex, pushed so strongly to be identified with the duo that it would allow them to talk to The Associated Press only if the article mentioned the two are promoting the watch makers social media campaign. … Continue reading →

ARDSLEY, NY (TheStreet) -- Acorda Therapeutics (ACOR) announced mixed results from two proof-of-concept studies Monday aimed at expanding the use of its multiple sclerosis walking drug Ampyra to include patients suffering from strokes and cerebral palsy. In a study of 83 patients who had experienced a stroke at least six months prior to enrollment, use of twice-daily Ampyra significantly improved walking ability compared to a placebo, Acorda said in a statement. The company didn't provide detailed data on Ampyra's efficacy Three patients reported seizures during the study. One seizure occurred in a patient treated with a placebo. The two other seizure cases involved patients on Ampyra, although one was deemed an intentional overdose and suicide attempt. "There were clear efficacy signals in the [Ampya] post-stroke deficits trial and we therefore plan to proceed with a clinical development program for this indication," said Acorda CEO Ron Cohen. To order reprints of this article, click here: Reprints EXCLUSIVE OFFER: Jim Cramer's Protg, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass. Continue reading here: Acorda Drug Helps Stroke Patients Walk Better … Continue reading →